For Research Use Only. This product is intended strictly for in-vitro laboratory research by licensed researchers and qualified professionals. It is not intended for human or animal consumption, therapeutic use, or self-administration. Not evaluated by the FDA. Handle per GLP guidelines.
Retatrutide is a synthetic investigational peptide functioning as a triple agonist at GIP, GLP-1, and glucagon receptors. It is an acylated peptide currently under preclinical and clinical investigation for metabolic research applications. Available exclusively for qualified researchers conducting in-vitro and laboratory studies.
- HPLC purity analysis confirming ≥99% peptide purity prior to release
- Mass spectrometry verification of molecular weight and compound identity
- Endotoxin tested — sterile filtered, packaged under Class 100,000 cleanroom conditions
- Certificate of Analysis matched to shipment by batch number
- Store lyophilized compound at -20°C, protected from light and moisture
- Reconstituted solutions: store at 4°C, use within 48–72 hours
- Avoid repeated freeze-thaw cycles to preserve compound integrity
- Handle under sterile conditions per GLP guidelines
Sold exclusively for in-vitro laboratory research. Not intended for human or animal administration, clinical trials, or diagnostic use. NexGen Research Labs assumes no liability for misuse outside of stated research application.
Third-Party Verified — Batch COA available upon request. Independent accredited laboratory testing on every lot.
Reviews
There are no reviews yet.